Testicular cancer survivors may have increased fatigue

the ONA take:

A recent study explored whether chronic fatigue is more prevalent in survivors of testicular cancer than the general population.

Researchers reviewed 812 testicular cancer survivors that were treated between 1980 and 1994. Respondents completed questionnaires and were also asked for blood samples.

Two surveys were conducted: Survey I (1998-2002) and Survey II (2007-2008). Logistic regression analysis was employed to examine associations between fatigue levels and Hospital Anxiety and Depression Scale (HADS), physical activity, hormone levels, treatment, neurotoxicity, and comorbidity.

The researchers, led by Dr. Jan Oldenburg (Department of Oncology, Akershus University Hospital, Lørenskog, Norway, & University of Oslo, Norway), found increased prevalence of chronic fatigue (15% up to 27% at Survey II). High neuropathy levels showed increased chronic fatigue (3-4-fold).

Higher levels of HADS-Anxiety and HADS-Depression showed increased chronic fatigue risk of 2-5-fold, respectively. Life style interventions, moderate physical activity, and treatment for depression/anxiety demonstrated some protective effect.

The study authors recommend additional research with extended, long-term follow-up reporting.

Men often respond to a cancer diagnosis by retreating emotionally.
Recent study explored whether chronic fatigue is more prevalent in survivors of testicular cancer than the general population.
Corresponding author: Dr. Jan Oldenburg, Department of Oncology, Akershus University Hospital, Lørenskog, Norway, & University of Oslo, Norway, Telephone: +47 915 02900, E-mail: jan.oldenburg{at}medisin.uio.no Background Chronic fatigue (CF) has been reported to be slightly more prevalent in Testicular Cancer Survivors (TCSs) than in the general population.
READ FULL ARTICLE From Annals of Oncology
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs